Stock fact sheet · data as of
Lantheus Holdings, Inc. (LNTH): fair value, margin of safety and Wheel Score
Healthcare · Drug Manufacturers - Specialty & Generic · United States · Blend
Is LNTH undervalued?
Lantheus Holdings, Inc. (LNTH) closed at 99.99 on 16 Oct 2026. The GLS average fair value - the simple average of the 8 valuation models that produced a positive number - is 183.99, which puts the price 46% below it. 5 of the 8 models value the shares above the current price. A gap this wide is rare in our universe of ~7,400 US stocks and is exactly what the Value part of the Wheel Score rewards; it is also where the question "why is it this cheap?" matters most.
The 8 models disagree widely: Graham Number gives 43.75 while DCF gives 501.30. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.
The nightly engine files LNTH under Blend.
Nine valuation models for LNTH
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 501.30 | +401% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 43.75 | -56% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 168.94 | +69% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 68.43 | -32% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 258.66 | +159% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 148.25 | +48% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 235.69 | +136% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | 46.95 | -53% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | -3.64 | -104% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 102.65 | +3% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is average - LNTH passes 5 of the nine Piotroski tests, which falls one point short of the Sunday Scan's "6 or more" rule. The Financials tab on the Quote page shows which tests fail. The GLS Moat score is low at 4.2 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.
Returns on capital are high - ROIC 13.7%, ROE 21.4%, ROA 10.5% - with debt at 0.57 times equity and a free-cash-flow yield of 5.9%.
Lantheus Holdings, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Product 35%, Oncology 23%, Pylarify 23% (quarter Q2 FY2026).
Institutional ownership scores 10/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 5 / 9 | ROIC | 13.7% |
|---|---|---|---|
| GLS Moat | 4.2 / 10 | ROE | 21.4% |
| Debt / equity | 0.57 | ROA | 10.5% |
| Free-cash-flow yield | 5.9% | Payout ratio | 0% |
| Institutions | 10 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 60: Fair
LNTH scores 60 out of 100 on the Wheel Score (Fair band, 50-64): a usable but unremarkable fit for the wheel strategy. The parts: Value 25/25, Health 11/20, Moat 6/15, Premium 1/20, Stability 17/20. Premium (1/20) is where the points are missing.
Implied volatility is 16% on the near-the-money contracts 20-60 days out: some premium, but under the 35-60% range the Wheel Score pays full marks for (1 of 20 points). Chain open interest is 11,152 contracts across all expiries - enough for the wheel at normal size.
Volume runs at 866k shares a day on a market cap of $6.5B, with a beta of -0.06 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 17 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 25 / 25 | 46% margin of safety | |
| Health | 11 / 20 | Piotroski 5/9 | |
| Moat | 6 / 15 | moat 4.2/10 | |
| Premium | 1 / 20 | implied volatility 16% | |
| Stability | 17 / 20 | 866k shares/day, $6.5B cap, beta -0.06 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
The next earnings report is due on 5 Nov 2026 (before the open), 20 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Drug Manufacturers - Specialty & Generic
The 12 companies below are the closest to Lantheus Holdings, Inc. by market cap within the Drug Manufacturers - Specialty & Generic industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| ALKS Alkermes plc | 40.10 | 22.14 | -81% | 56Fair | $6.7B |
| AMRX Amneal Pharmaceuticals, Inc. | 19.25 | 12.43 | -55% | 57Fair | $6.1B |
| INDV Indivior Pharmaceuticals Inc | 33.62 | 56.88 | +41% | 75Good | $4.2B |
| RGC Regencell Bioscience Holdings Limited | 8.11 | 0.0281 | -28765% | 25Weak | $4.0B |
| RDY Dr. Reddy's Laboratories Limited | 12.75 | 153.50 | +92% | 82Prime | $10.6B |
| ELAN Elanco Animal Health Incorporated | 23.54 | 11.45 | -106% | 45Weak | $11.8B |
| HCM HUTCHMED (China) Limited | 13.94 | 2.93 | -376% | 42Weak | $2.4B |
| BHC Bausch Health Companies Inc. | 6.31 | 134.93 | +95% | 45Weak | $2.4B |
| SUPN Supernus Pharmaceuticals, Inc. | 40.18 | 46.46 | +14% | 45Weak | $2.3B |
| PRGO Perrigo Company plc | 15.95 | 37.60 | +58% | 45Weak | $2.2B |
| VTRS Viatris Inc. | 17.44 | 18.82 | +7% | 45Weak | $20.0B |
| ALVO Alvotech | 5.31 | - | - | 33No options | $1.9B |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about LNTH
Is LNTH undervalued right now?
By the GLS models, yes: at 99.99 the stock is 46% below the average fair value of 183.99 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of LNTH and what does it mean?
LNTH scores 60 out of 100 (Fair). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for LNTH?
183.99 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Lantheus Holdings, Inc. report earnings next?
The next earnings report is due on 5 Nov 2026 (before the open), 20 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does LNTH have listed options, and how liquid are they?
Yes. The nightly snapshot found 374 listed contracts with 11,152 open interest across all expiries and implied volatility of 16% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.